- Investopedia•3 days ago
Cytokinetics' spinal muscular atrophy drug, CK-2127107, improved muscle function in a pre-clinical study.
- Zacks•4 days ago
Biotech stocks were hit by the 2018 budget blueprint as well as news on companies like Amgen (AMGN) and Biogen.
- Market Realist•4 days ago
Ionis Pharmaceuticals’ (IONS) Spinraza (nusinersen) is designed for the treatment of spinal muscular atrophy, a type of severe motor-neuron disease.
BIIB : Summary for Biogen Inc. - Yahoo Finance
Biogen Inc. (BIIB)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||270.00 x 100|
|Ask||276.80 x 300|
|Day's Range||272.87 - 278.10|
|52 Week Range||223.02 - 333.65|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||16.23|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|